Exelixis EXEL
NASDAQ EXEL
$58.41 -0.24 (-0.41%)
At close: Sep 30, 2026 · 4:00 PM EDT

Exelixis (EXEL) Deferred Taxes (2018 - 2022)

Updated

Exelixis (EXEL) recorded Deferred Taxes of -$126.24 million in FY2026, compared with $59.46 million in FY2025.

Analysis

Exelixis (EXEL) Deferred Taxes (2018 - 2022) Analysis & Trends

Starting with FY2018, Exelixis' Deferred Taxes history includes 7 years.

  • The FY2026 figure is the lowest annual Deferred Taxes in data going back to FY2018.
  • Per Business Quant data, EXEL's Deferred Taxes was $59.46 million in FY2025, $133.21 million in FY2023 (+120.7%) and $60.36 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -479.00 Mn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -195.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -544.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -398.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -291.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -587.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.32 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Exelixis 14.60 Bn 10.93 Bn 608.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 30, 2022 60.36 Mn
Jul 1, 2022 15.32 Mn
Apr 1, 2022 -15.32 Mn
Dec 31, 2021 -14.16 Mn
Oct 1, 2021 -9.57 Mn
Jul 2, 2021 -26.19 Mn
Apr 2, 2021 3.39 Mn
Jan 1, 2021 -71.60 Mn
Apr 3, 2020 -10.13 Mn
Sep 27, 2019 23.27 Mn
Jun 28, 2019 33.07 Mn
Dec 28, 2018 244.11 Mn
API Access

Exelixis Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=EXEL&period=max&api_key=YOUR_API_KEY